Cambridge Investment Research Advisors
KIDS icon

Cambridge Investment Research Advisors’s OrthoPediatrics KIDS Stock Holding History

Cambridge Investment Research Advisors’s Portfolio KIDS Stock Details KIDS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-11,705
Closed -$217K – 3899
2025
Q3 		$217K Sell
11,705
-3,000
-20% -$61.8K ﹤0.01% 3414
2025
Q2 		$316K Buy
+14,705
New +$318K ﹤0.01% 2937

Other funds holding KIDS

Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Cambridge Investment Research Advisors's KIDS Position: Q4 2025 in Review

Cambridge Investment Research Advisors sold out of OrthoPediatrics (KIDS) in Q4 2025, closing a stake of 11,705 shares — an estimated $217K sold.

Cambridge Investment Research Advisors first reported a position in KIDS in Q2 2025 and held it in 2 quarters. The position peaked at $316K in Q2 2025. 120 funds tracked by Wall St. Rank hold KIDS as of Q4 2025.

  • Cambridge Investment Research Advisors reported no remaining OrthoPediatrics position as of Q4 2025 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 11,705 OrthoPediatrics shares in Q4 2025, an estimated $217K.
  • Cambridge Investment Research Advisors first reported a position in OrthoPediatrics in Q2 2025 and held it in 2 quarters.
  • Cambridge Investment Research Advisors's OrthoPediatrics position peaked at $316K in Q2 2025.
  • 120 funds tracked by Wall St. Rank held OrthoPediatrics as of Q4 2025.

Based on Cambridge Investment Research Advisors's 13F filing for Q4 2025, filed 5 Feb 2026.